Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 8, Pages 1409-1417
Publisher
Springer Nature
Online
2012-10-11
DOI
10.1038/bjc.2012.391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status
- (2011) Xiang Guo et al. BMC Medical Genomics
- c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
- (2011) J. Rauch et al. CANCER RESEARCH
- Genome-Wide Analysis of Alternative Splicing in Medulloblastoma Identifies Splicing Patterns Characteristic of Normal Cerebellar Development
- (2011) F. Menghi et al. CANCER RESEARCH
- Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development
- (2011) Sharmistha Pal et al. GENOME RESEARCH
- A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at theTRKAandp75NTRPromoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF
- (2010) Nunzio Iraci et al. CANCER RESEARCH
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis
- (2010) Derek M. Murphy et al. MOLECULAR CARCINOGENESIS
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Molecular pathogenesis of peripheral neuroblastic tumors
- (2010) I Janoueix-Lerosey et al. ONCOGENE
- 59-gene prognostic signature sub-stratifies high-risk neuroblastoma patients
- (2009) Joëlle Vermeulen et al. LANCET ONCOLOGY
- Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
- (2009) Joëlle Vermeulen et al. LANCET ONCOLOGY
- An integrated cross-platform prognosis study on neuroblastoma patients
- (2008) Qing-Rong Chen et al. GENOMICS
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2008) Julie R. Park et al. PEDIATRIC CLINICS OF NORTH AMERICA
- MYCN regulates oncogenic MicroRNAs in neuroblastoma
- (2007) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search